Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt 3.96
SIAL's Cash to Debt is ranked higher than
63% of the 1067 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.98 vs. SIAL: 3.96 )
Ranked among companies with meaningful Cash to Debt only.
SIAL' s Cash to Debt Range Over the Past 10 Years
Min: 0.08  Med: 0.76 Max: 9.98
Current: 3.96
0.08
9.98
Equity to Asset 0.76
SIAL's Equity to Asset is ranked higher than
78% of the 1029 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.54 vs. SIAL: 0.76 )
Ranked among companies with meaningful Equity to Asset only.
SIAL' s Equity to Asset Range Over the Past 10 Years
Min: 0.53  Med: 0.66 Max: 0.88
Current: 0.76
0.53
0.88
Interest Coverage 84.38
SIAL's Interest Coverage is ranked higher than
76% of the 744 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 15.94 vs. SIAL: 84.38 )
Ranked among companies with meaningful Interest Coverage only.
SIAL' s Interest Coverage Range Over the Past 10 Years
Min: 14.27  Med: 60.19 Max: 170.25
Current: 84.38
14.27
170.25
F-Score: 5
Z-Score: 12.78
M-Score: -2.69
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 24.27
SIAL's Operating margin (%) is ranked higher than
94% of the 1047 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 6.31 vs. SIAL: 24.27 )
Ranked among companies with meaningful Operating margin (%) only.
SIAL' s Operating margin (%) Range Over the Past 10 Years
Min: 15.5  Med: 23.77 Max: 25.83
Current: 24.27
15.5
25.83
Net-margin (%) 17.73
SIAL's Net-margin (%) is ranked higher than
93% of the 1051 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 4.59 vs. SIAL: 17.73 )
Ranked among companies with meaningful Net-margin (%) only.
SIAL' s Net-margin (%) Range Over the Past 10 Years
Min: 15.26  Med: 16.53 Max: 18.24
Current: 17.73
15.26
18.24
ROE (%) 15.34
SIAL's ROE (%) is ranked higher than
76% of the 1030 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 7.91 vs. SIAL: 15.34 )
Ranked among companies with meaningful ROE (%) only.
SIAL' s ROE (%) Range Over the Past 10 Years
Min: 16.6  Med: 20.96 Max: 22.8
Current: 15.34
16.6
22.8
ROA (%) 11.72
SIAL's ROA (%) is ranked higher than
87% of the 1070 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 3.88 vs. SIAL: 11.72 )
Ranked among companies with meaningful ROA (%) only.
SIAL' s ROA (%) Range Over the Past 10 Years
Min: 12.4  Med: 13.07 Max: 14.52
Current: 11.72
12.4
14.52
ROC (Joel Greenblatt) (%) 40.54
SIAL's ROC (Joel Greenblatt) (%) is ranked higher than
89% of the 1060 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 12.36 vs. SIAL: 40.54 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
SIAL' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 31.31  Med: 36.57 Max: 42.45
Current: 40.54
31.31
42.45
Revenue Growth (3Y)(%) 4.50
SIAL's Revenue Growth (3Y)(%) is ranked higher than
61% of the 930 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 2.00 vs. SIAL: 4.50 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
SIAL' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 0.4  Med: 10.80 Max: 16.1
Current: 4.5
0.4
16.1
EBITDA Growth (3Y)(%) 3.40
SIAL's EBITDA Growth (3Y)(%) is ranked lower than
54% of the 822 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 5.40 vs. SIAL: 3.40 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
SIAL' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: 2.1  Med: 10.80 Max: 17.9
Current: 3.4
2.1
17.9
EPS Growth (3Y)(%) 3.90
SIAL's EPS Growth (3Y)(%) is ranked lower than
57% of the 727 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 8.70 vs. SIAL: 3.90 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
SIAL' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -0.2  Med: 11.90 Max: 20
Current: 3.9
-0.2
20
» SIAL's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-07-23)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q1 2015

SIAL Guru Trades in Q1 2015

Jim Simons 861,132 sh (+36.40%)
Mario Gabelli 434,150 sh (+16.13%)
Dodge & Cox 19,000 sh (unchged)
First Pacific Advisors 2,700 sh (unchged)
First Eagle Investment 12,500 sh (unchged)
Chris Davis Sold Out
Caxton Associates Sold Out
Yacktman Fund 800,000 sh (-5.44%)
Donald Yacktman 1,428,207 sh (-8.42%)
Mairs and Power 5,613 sh (-9.67%)
Yacktman Focused Fund 400,000 sh (-15.20%)
Jeremy Grantham 809,034 sh (-23.65%)
Joel Greenblatt 1,512 sh (-66.60%)
Murray Stahl 24,890 sh (-70.91%)
» More
Q2 2015

SIAL Guru Trades in Q2 2015

George Soros 108,381 sh (New)
Paul Tudor Jones 180,700 sh (New)
Mario Gabelli 454,250 sh (+4.63%)
Yacktman Fund 800,000 sh (unchged)
Yacktman Focused Fund 400,000 sh (unchged)
Dodge & Cox 19,000 sh (unchged)
First Pacific Advisors 2,700 sh (unchged)
First Eagle Investment Sold Out
Joel Greenblatt Sold Out
Mairs and Power 5,593 sh (-0.36%)
Donald Yacktman 1,408,946 sh (-1.35%)
Murray Stahl 23,671 sh (-4.90%)
Jim Simons 677,932 sh (-21.27%)
Jeremy Grantham 181,987 sh (-77.51%)
» More
Q3 2015

SIAL Guru Trades in Q3 2015

Jim Simons 2,374,400 sh (+250.24%)
George Soros 108,381 sh (unchged)
First Pacific Advisors 2,700 sh (unchged)
Dodge & Cox 19,000 sh (unchged)
Yacktman Focused Fund Sold Out
Yacktman Fund Sold Out
Paul Tudor Jones 180,000 sh (-0.39%)
Murray Stahl 21,186 sh (-10.50%)
Mairs and Power 4,992 sh (-10.75%)
Mario Gabelli 369,400 sh (-18.68%)
Donald Yacktman 92,627 sh (-93.43%)
Jeremy Grantham 6,981 sh (-96.16%)
» More
Q4 2015

SIAL Guru Trades in Q4 2015

Murray Stahl Sold Out
Donald Yacktman Sold Out
Mario Gabelli Sold Out
Jim Simons Sold Out
Dodge & Cox Sold Out
Jeremy Grantham Sold Out
George Soros Sold Out
Paul Tudor Jones Sold Out
First Pacific Advisors Sold Out
Mairs and Power Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with SIAL

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Chemicals » Specialty Chemicals
Compare:NYSE:LYB, NYSE:ECL, NYSE:PX, NYSE:PPG, NYSE:SHW, XSWX:GIVN » details
Traded in other countries:SIQ.Germany,


Sigma-Aldrich Corp was incorporated under the laws of the State of Delaware in May 1975. The Company is a life science and a technology company that helps in enhancing human health and safety. The Company manufactures and distributes chemicals, biochemicals and other essential products and equipment products to its customers in research and applied labs as well as in industrial and commercial markets. The Company operates in three units including Research, Applied and SAFC Commercial. The Research unit products and services includes chemicals, reagents and kits, enabling the scientists to discover and develop new drugs and materials; Applied unit products and services includes high quality components and kits, chemical reagents, critical raw materials and certified reference standards, providing customized solutions to and constitute critical components and materials for diagnostic companies, testing laboratories and industrial companies; SAFC Commercial unit's products and services are used by its customers to develop and manufacture pharma, biopharma and electronics products. Its customers include pharmaceutical companies, universities, commercial laboratories, industrial companies, biotechnology companies, non-profit organizations, governmental institutions, diagnostic, chemical and electronics companies and hospitals. The Company's trademarks are the brand names; Sigma-Aldrich, Sigma, Aldrich, Fluka, Riedel-de Haën, Supelco, SAFC, SAFC Biosciences, SAFC Hitech, Genosys, Proligo, Pharmorphix, Cerilliant, Vetec, BioReliance and Cell Marque. The Company is subject to extensive regulation by federal, state and local governments and similar international agencies relating to the manufacture, sale and distribution of its products.

Guru Investment Theses on Sigma-Aldrich Corp

Mario Gabelli Comments on Sigma-Aldrich Corp - Oct 19, 2015

Sigma-Aldrich Corp. (NASDAQ:SIAL)(4.4%) (SIAL – $138.92 – NASDAQ) is a leading life science and technology company based in St. Louis, Missouri that manufactures and distributes more than 230,000 chemicals, biochemical, and other essential products to more than 1.4 million customers globally. On September 22, 2014, Merck KGaA, a German multinational pharmaceutical and chemical company, announced that it would acquire Sigma-Aldrich for $16.7 billion, or $140 cash per share. The deal received shareholder and regulatory approvals and should close within the next two months, pending completion of divestitures in the EU.



From Mario Gabelli (Trades, Portfolio)'s third quarter 2015 ABC Fund commentary.

Check out Mario Gabelli latest stock trades

Top Ranked Articles about Sigma-Aldrich Corp

Mario Gabelli Comments on Sigma-Aldrich Corp Guru stock highlight
Sigma-Aldrich Corp. (NASDAQ:SIAL)(4.4%) (SIAL – $138.92 – NASDAQ) is a leading life science and technology company based in St. Louis, Missouri that manufactures and distributes more than 230,000 chemicals, biochemical, and other essential products to more than 1.4 million customers globally. On September 22, 2014, Merck KGaA, a German multinational pharmaceutical and chemical company, announced that it would acquire Sigma-Aldrich for $16.7 billion, or $140 cash per share. The deal received shareholder and regulatory approvals and should close within the next two months, pending completion of divestitures in the EU. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 34.34
SIAL's P/E(ttm) is ranked lower than
76% of the 872 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 16.02 vs. SIAL: 34.34 )
Ranked among companies with meaningful P/E(ttm) only.
SIAL' s P/E(ttm) Range Over the Past 10 Years
Min: 12.12  Med: 19.75 Max: 34.67
Current: 34.34
12.12
34.67
Forward P/E 29.50
SIAL's Forward P/E is ranked lower than
97% of the 109 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 13.85 vs. SIAL: 29.50 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 34.34
SIAL's PE(NRI) is ranked lower than
75% of the 855 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 16.31 vs. SIAL: 34.34 )
Ranked among companies with meaningful PE(NRI) only.
SIAL' s PE(NRI) Range Over the Past 10 Years
Min: 12.14  Med: 19.79 Max: 34.65
Current: 34.34
12.14
34.65
Price/Owner Earnings (ttm) 29.83
SIAL's Price/Owner Earnings (ttm) is ranked lower than
70% of the 462 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 17.34 vs. SIAL: 29.83 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
SIAL' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 11.16  Med: 19.87 Max: 32.19
Current: 29.83
11.16
32.19
P/B 4.99
SIAL's P/B is ranked lower than
86% of the 1050 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.59 vs. SIAL: 4.99 )
Ranked among companies with meaningful P/B only.
SIAL' s P/B Range Over the Past 10 Years
Min: 2.87  Med: 3.79 Max: 5.28
Current: 4.99
2.87
5.28
P/S 6.08
SIAL's P/S is ranked lower than
90% of the 1062 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.03 vs. SIAL: 6.08 )
Ranked among companies with meaningful P/S only.
SIAL' s P/S Range Over the Past 10 Years
Min: 1.92  Med: 3.35 Max: 6.09
Current: 6.08
1.92
6.09
PFCF 31.79
SIAL's PFCF is ranked lower than
79% of the 394 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 15.05 vs. SIAL: 31.79 )
Ranked among companies with meaningful PFCF only.
SIAL' s PFCF Range Over the Past 10 Years
Min: 12.54  Med: 20.76 Max: 33.24
Current: 31.79
12.54
33.24
POCF 25.66
SIAL's POCF is ranked lower than
89% of the 494 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 8.41 vs. SIAL: 25.66 )
Ranked among companies with meaningful POCF only.
SIAL' s POCF Range Over the Past 10 Years
Min: 9.64  Med: 16.29 Max: 26.98
Current: 25.66
9.64
26.98
EV-to-EBIT 23.53
SIAL's EV-to-EBIT is ranked lower than
72% of the 890 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 12.76 vs. SIAL: 23.53 )
Ranked among companies with meaningful EV-to-EBIT only.
SIAL' s EV-to-EBIT Range Over the Past 10 Years
Min: 8.7  Med: 14.10 Max: 24.4
Current: 23.53
8.7
24.4
EV-to-EBITDA 19.70
SIAL's EV-to-EBITDA is ranked lower than
74% of the 922 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 9.89 vs. SIAL: 19.70 )
Ranked among companies with meaningful EV-to-EBITDA only.
SIAL' s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.3  Med: 11.70 Max: 20.4
Current: 19.7
7.3
20.4
PEG 4.64
SIAL's PEG is ranked lower than
71% of the 417 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 2.07 vs. SIAL: 4.64 )
Ranked among companies with meaningful PEG only.
SIAL' s PEG Range Over the Past 10 Years
Min: 0.89  Med: 1.88 Max: 6.77
Current: 4.64
0.89
6.77
Shiller P/E 40.75
SIAL's Shiller P/E is ranked lower than
70% of the 164 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 28.97 vs. SIAL: 40.75 )
Ranked among companies with meaningful Shiller P/E only.
SIAL' s Shiller P/E Range Over the Past 10 Years
Min: 17.47  Med: 28.08 Max: 42.69
Current: 40.75
17.47
42.69
Current Ratio 4.95
SIAL's Current Ratio is ranked higher than
90% of the 925 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.75 vs. SIAL: 4.95 )
Ranked among companies with meaningful Current Ratio only.
SIAL' s Current Ratio Range Over the Past 10 Years
Min: 1.54  Med: 3.00 Max: 7.34
Current: 4.95
1.54
7.34
Quick Ratio 3.43
SIAL's Quick Ratio is ranked higher than
87% of the 925 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.28 vs. SIAL: 3.43 )
Ranked among companies with meaningful Quick Ratio only.
SIAL' s Quick Ratio Range Over the Past 10 Years
Min: 0.58  Med: 1.56 Max: 4
Current: 3.43
0.58
4
Days Inventory 197.85
SIAL's Days Inventory is ranked lower than
94% of the 1007 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 67.04 vs. SIAL: 197.85 )
Ranked among companies with meaningful Days Inventory only.
SIAL' s Days Inventory Range Over the Past 10 Years
Min: 186.78  Med: 212.83 Max: 238.48
Current: 197.85
186.78
238.48
Days Sales Outstanding 53.42
SIAL's Days Sales Outstanding is ranked higher than
57% of the 846 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 58.71 vs. SIAL: 53.42 )
Ranked among companies with meaningful Days Sales Outstanding only.
SIAL' s Days Sales Outstanding Range Over the Past 10 Years
Min: 44.75  Med: 48.95 Max: 52.03
Current: 53.42
44.75
52.03
Days Payable 56.68
SIAL's Days Payable is ranked higher than
60% of the 897 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 47.82 vs. SIAL: 56.68 )
Ranked among companies with meaningful Days Payable only.
SIAL' s Days Payable Range Over the Past 10 Years
Min: 38.64  Med: 41.20 Max: 48.9
Current: 56.68
38.64
48.9

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.66
SIAL's Dividend Yield is ranked lower than
87% of the 1032 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 2.21 vs. SIAL: 0.66 )
Ranked among companies with meaningful Dividend Yield only.
SIAL' s Dividend Yield Range Over the Past 10 Years
Min: 0.66  Med: 1.03 Max: 1.64
Current: 0.66
0.66
1.64
Dividend Payout 0.23
SIAL's Dividend Payout is ranked higher than
65% of the 694 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.30 vs. SIAL: 0.23 )
Ranked among companies with meaningful Dividend Payout only.
SIAL' s Dividend Payout Range Over the Past 10 Years
Min: 0.11  Med: 0.20 Max: 0.26
Current: 0.23
0.11
0.26
Dividend Growth (3y) 8.50
SIAL's Dividend Growth (3y) is ranked higher than
63% of the 531 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 3.80 vs. SIAL: 8.50 )
Ranked among companies with meaningful Dividend Growth (3y) only.
SIAL' s Dividend Growth (3y) Range Over the Past 10 Years
Min: 5.3  Med: 11.30 Max: 30
Current: 8.5
5.3
30
Forward Dividend Yield 0.66
SIAL's Forward Dividend Yield is ranked lower than
88% of the 987 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 2.30 vs. SIAL: 0.66 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 1.06
SIAL's Yield on cost (5-Year) is ranked lower than
80% of the 1189 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 2.63 vs. SIAL: 1.06 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
SIAL' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 1.06  Med: 1.65 Max: 2.63
Current: 1.06
1.06
2.63
3-Year Average Share Buyback Ratio 0.60
SIAL's 3-Year Average Share Buyback Ratio is ranked higher than
84% of the 463 Companies
in the Global Specialty Chemicals industry.

( Industry Median: -1.70 vs. SIAL: 0.60 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
SIAL' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -0.3  Med: 1.90 Max: 10.2
Current: 0.6
-0.3
10.2

Valuation & Return

vs
industry
vs
history
Price/Net Cash 138.38
SIAL's Price/Net Cash is ranked lower than
94% of the 141 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 12.45 vs. SIAL: 138.38 )
Ranked among companies with meaningful Price/Net Cash only.
SIAL' s Price/Net Cash Range Over the Past 10 Years
Min: 137.54  Med: 341.00 Max: 4608.33
Current: 138.38
137.54
4608.33
Price/Net Current Asset Value 11.70
SIAL's Price/Net Current Asset Value is ranked lower than
69% of the 475 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 5.45 vs. SIAL: 11.70 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
SIAL' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 4.86  Med: 13.28 Max: 188.41
Current: 11.7
4.86
188.41
Price/Tangible Book 7.19
SIAL's Price/Tangible Book is ranked lower than
90% of the 1003 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.63 vs. SIAL: 7.19 )
Ranked among companies with meaningful Price/Tangible Book only.
SIAL' s Price/Tangible Book Range Over the Past 10 Years
Min: 2.45  Med: 4.96 Max: 7.85
Current: 7.19
2.45
7.85
Price/Projected FCF 2.24
SIAL's Price/Projected FCF is ranked lower than
75% of the 512 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.17 vs. SIAL: 2.24 )
Ranked among companies with meaningful Price/Projected FCF only.
SIAL' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.9  Med: 1.41 Max: 2.94
Current: 2.24
0.9
2.94
Price/DCF (Earnings Based) 2.31
SIAL's Price/DCF (Earnings Based) is ranked lower than
77% of the 60 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.57 vs. SIAL: 2.31 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.82
SIAL's Price/Median PS Value is ranked lower than
81% of the 1029 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.13 vs. SIAL: 1.82 )
Ranked among companies with meaningful Price/Median PS Value only.
SIAL' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.66  Med: 0.92 Max: 1.81
Current: 1.82
0.66
1.81
Price/Peter Lynch Fair Value 6.76
SIAL's Price/Peter Lynch Fair Value is ranked lower than
96% of the 224 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.26 vs. SIAL: 6.76 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
SIAL' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 1.03  Med: 1.89 Max: 6.72
Current: 6.76
1.03
6.72
Price/Graham Number 3.31
SIAL's Price/Graham Number is ranked lower than
83% of the 721 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.09 vs. SIAL: 3.31 )
Ranked among companies with meaningful Price/Graham Number only.
SIAL' s Price/Graham Number Range Over the Past 10 Years
Min: 1.37  Med: 2.09 Max: 3.39
Current: 3.31
1.37
3.39
Earnings Yield (Greenblatt) (%) 4.20
SIAL's Earnings Yield (Greenblatt) (%) is ranked lower than
58% of the 1098 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 5.70 vs. SIAL: 4.20 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
SIAL' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 4.1  Med: 7.10 Max: 11.5
Current: 4.2
4.1
11.5
Forward Rate of Return (Yacktman) (%) 7.91
SIAL's Forward Rate of Return (Yacktman) (%) is ranked higher than
58% of the 550 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 4.74 vs. SIAL: 7.91 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
SIAL' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 7.9  Med: 15.40 Max: 19.9
Current: 7.91
7.9
19.9

More Statistics

Revenue (TTM) (Mil) $2,781
EPS (TTM) $ 4.07
Short Percentage of Float2.67%
52-Week Range $135.33 - 140.03
Shares Outstanding (Mil)119.80

Analyst Estimate

Dec15 Dec16
Revenue (Mil $) 2,767 2,928
EPS ($) 4.34 4.74
EPS without NRI ($) 4.34 4.74
EPS Growth Rate
(3Y to 5Y Estimate)
12.10%
» More Articles for SIAL

Headlines

Articles On GuruFocus.com
Jim Simons' 3rd-Quarter Transactions Involve Big-Name Companies Dec 02 2015 
Mario Gabelli Comments on Sigma-Aldrich Corp Oct 19 2015 
Yacktman Fund Reduces Positions in PepsiCo, Coca-Cola in Third Quarter Oct 15 2015 
Broadcom, Pall Corp. Among Paul Tudor Jones' Recent Buys Sep 20 2015 
Weekly 52-Week Highs Highlight: Tim Hortons, Hospira, Kinder Morgan, Sigma-Aldrich Aug 25 2015 
Mario Gabelli's ABC Fund Merger and Arbitrage 'The Deal Fund' Q2 Commentary Jul 23 2015 
Weekly 52-Week Highs Highlight: SIAL, GIS, TJX, HSP Mar 30 2015 
Searching For Stocks With Solid Dividend Increases Jan 27 2015 
World Economic Forum 2015 – What To Look Forward For Jan 18 2015 
Weekly 52-Week Highs Highlight: HCP, SIAL, SBUX, KR Dec 14 2014 

More From Other Websites
Merck KGaA's Q1 Earnings Increase Y/Y, Offers 2016 View May 20 2016
Merck KGaA (MKGAF) Q1 Earnings Increased Y/Y May 19 2016
[$$] Germany's Merck Lifted by Sigma-Aldrich Deal May 19 2016
Merck Increases Sales and Earnings in Q1 Following Sigma-Aldrich Acquisition May 19 2016
Merck KGaA (MKGAF) Q1 Earnings: What Awaits the Stock? May 16 2016
Annual Report & Accounts and Notice of Meeting Apr 15 2016
DIRECTORS/PDMR SHAREHOLDING Apr 05 2016
[$$] Germany's Merck Boosted by Life Sciences Mar 08 2016
Merck KGaA (MKGAF) Q4 Earnings Decline Y/Y Mar 08 2016
Merck KGaA aims for 2016 earnings growth thanks to takeover Mar 08 2016
BLOCK LISTING SIX MONTHLY RETURN Jan 21 2016
DIRECTORS/PDMR SHAREHOLDING Jan 15 2016
DIRECTORS/PDMR SHAREHOLDING Jan 11 2016
DIRECTORS/PDMR SHAREHOLDING Dec 31 2015
Management Changes Dec 17 2015
Former Sigma-Aldrich CEO named chief executive of Florida firm Dec 16 2015
Merck KGaA Said to Weigh Selling its Allergy Therapy Unit Nov 26 2015
DIRECTORS/PDMR SHAREHOLDING Nov 23 2015
These 5 Stocks Dominate Farallon Capital’s Portfolio Nov 22 2015
SIGMA ALDRICH CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits Nov 18 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)